Metastatic Renal Cell Carcinoma Completed Phase 1 / 2 Trials for Everolimus (DB01590)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01136733A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted TreatmentTreatment